Insight Molecular Diagnostics (IMDX) SEC Filings: History & Chart

Insight Molecular Diagnostics Inc.(IMDX)

Medical - Diagnostics & Research · Nashville, TN

$3.51-0.16 (-4.36%)

Delayed quote: Oct 6, 2026, 12:50 PM EDT

About Insight Molecular Diagnostics Inc.

OncoCyte Corporation functions as a molecular diagnostics firm specializing in the research, development, and market introduction of distinctive, laboratory-developed tests aimed at cancer identification. Its operations span both the United States and international territories. The company's key offerings include DetermaRx, a molecular diagnostic tool tailored for detecting early-stage adenocarcinoma of the lung, and DetermaIO, a proprietary gene expression analysis. Additionally, OncoCyte provides a range of expert services, such as biomarker discovery, assay design and refinement, and clinical trial assistance, which encompass offering various biomarker tests to pharmaceutical partners. A strategic partnership with Life Technologies Corporation focuses on the collaborative development and commercialization of the Oncomine Comprehensive Assay Plus and Determa IO assay, intended for integration with the Ion Torrent Genexus integrated sequencer and purification system. OncoCyte Corporation was founded in 2009 and maintains its principal office in Irvine, California.

Nashville, TN

57 employees

imdxinc.com

Healthcare / Medical - Diagnostics & Research

Sector: Healthcare
Industry: Medical - Diagnostics & Research
CEO: Joshua Riggs

View full financials

Form	Filing Date	Accepted	Document
8-K	Sep 21, 2026	Sep 21, 2026	View filing
10-Q	Aug 10, 2026	Aug 10, 2026	View filing
8-K	Aug 10, 2026	Aug 10, 2026	View filing
S-8	Jul 24, 2026	Jul 24, 2026	View filing
4	Jul 6, 2026	Jul 6, 2026	View filing
4	Jul 6, 2026	Jul 6, 2026	View filing
4	Jul 6, 2026	Jul 6, 2026	View filing
8-K	Jun 17, 2026	Jun 17, 2026	View filing
4	Jun 15, 2026	Jun 15, 2026	View filing
4	Jun 15, 2026	Jun 15, 2026	View filing
4	Jun 15, 2026	Jun 15, 2026	View filing
10-Q	May 13, 2026	May 13, 2026	View filing
8-K	May 13, 2026	May 13, 2026	View filing
8-K/A	May 13, 2026	May 13, 2026	View filing
ARS	Apr 30, 2026	Apr 30, 2026	View filing
DEFA14A	Apr 30, 2026	Apr 30, 2026	View filing
DEF 14A	Apr 30, 2026	Apr 30, 2026	View filing
8-K	Apr 30, 2026	Apr 30, 2026	View filing
SC 13D/A	Apr 27, 2026	Apr 27, 2026	View filing
4	Apr 27, 2026	Apr 27, 2026	View filing
4	Apr 20, 2026	Apr 20, 2026	View filing
4	Mar 30, 2026	Mar 30, 2026	View filing
4	Mar 30, 2026	Mar 30, 2026	View filing
4	Mar 30, 2026	Mar 30, 2026	View filing
10-K	Mar 26, 2026	Mar 26, 2026	View filing
8-K	Mar 26, 2026	Mar 26, 2026	View filing
8-K	Feb 26, 2026	Feb 26, 2026	View filing
SC 13D/A	Feb 12, 2026	Feb 12, 2026	View filing
4	Feb 12, 2026	Feb 12, 2026	View filing
8-K	Feb 12, 2026	Feb 12, 2026	View filing

SEC Filings

Recent Filings